AI assistant
HEALTHEQUITY, INC. — Director's Dealing 2016
Oct 26, 2016
30722_dirs_2016-10-26_d8370c4a-1488-4fd2-970f-bfc081ad5efd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHEQUITY INC (HQY)
CIK: 0001428336
Period of Report: 2016-10-25
Reporting Person: Medici Frank (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-10-25 | Common Stock | S | 2205884 | $35.85 | Disposed | 9763266 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $21.27 | 2026-02-01 | Common Stock (15000) | 15000 | Direct |
| Restricted Stock Units | $ | Common Stock (1640) | 1640 | Direct | |
| Stock Option (right to buy) | $14 | 2024-07-30 | Common Stock (22500) | 22500 | Direct |
| Stock Option (right to buy) | $25.39 | 2025-03-26 | Common Stock (15000) | 15000 | Direct |
Footnotes
F1: Price of $35.85 does not reflect underwriter discount or fees.
F2: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.
F3: The option became exercisable as to 7,500 shares upon the reporting person's reelection to the issuer's board of directors at the issuer's 2016 Annual Meeting of Stockholders held on June 23, 2016. The remaining 7,500 shares will become exercisable on January 31, 2017; provided, that the reporting person continues to serve as a director of the issuer through such date.
F4: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F5: The restricted stock units vested as to 546 shares on May 1, 2016. The remaining restricted stock units vest in two equal installments of 547 shares on August 1, 2016 and November 1, 2016. Vested shares will be delivered to the reporting person on January 1, 2020.
F6: The option is immediately exercisable.